De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm.
Publication
, Journal Article
Kearney, E; Collins, T; Sengupta, S
Published in: Headache
July 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Headache
DOI
EISSN
1526-4610
Publication Date
July 2020
Volume
60
Issue
7
Start / End Page
1435 / 1437
Location
United States
Related Subject Headings
- Vision Disorders
- Neurology & Neurosurgery
- Migraine without Aura
- Migraine with Aura
- Middle Aged
- Humans
- Female
- Calcitonin Gene-Related Peptide
- Antibodies, Monoclonal, Humanized
- 3209 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kearney, E., Collins, T., & Sengupta, S. (2020). De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm. Headache, 60(7), 1435–1437. https://doi.org/10.1111/head.13855
Kearney, Elizabeth, Timothy Collins, and Sweta Sengupta. “De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm.” Headache 60, no. 7 (July 2020): 1435–37. https://doi.org/10.1111/head.13855.
Kearney E, Collins T, Sengupta S. De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm. Headache. 2020 Jul;60(7):1435–7.
Kearney, Elizabeth, et al. “De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm.” Headache, vol. 60, no. 7, July 2020, pp. 1435–37. Pubmed, doi:10.1111/head.13855.
Kearney E, Collins T, Sengupta S. De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm. Headache. 2020 Jul;60(7):1435–1437.
Published In
Headache
DOI
EISSN
1526-4610
Publication Date
July 2020
Volume
60
Issue
7
Start / End Page
1435 / 1437
Location
United States
Related Subject Headings
- Vision Disorders
- Neurology & Neurosurgery
- Migraine without Aura
- Migraine with Aura
- Middle Aged
- Humans
- Female
- Calcitonin Gene-Related Peptide
- Antibodies, Monoclonal, Humanized
- 3209 Neurosciences